Title 2. Nguyễn Lương Kỷ.pdf ✅

TS.BS. NGUYỄN LƯƠNG KỶ Bệnh viện đa khoa tỉnh Khánh Hòa ĐIỀU TRỊ THIẾU MÁU Ở BỆNH NHÂN LỌC MÁU CHU KỲ: NHỮNG ĐIỀU CẦN LƯU Ý 1
Jager, K. J, et al (2019), A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases, Kidney International. Kovesdy C. P. (2022), Epidemiology of chronic kidney disease: an update 2022, Kidney international supplements, 12(1), 7–11. Tỷ lệ mắc CKD toàn cầu là 11,1% (10,4% ở nam giới và 11,8% ở nữ giới) 3,5 3,9 7,6 0,4 0,1 0 1 2 3 4 5 6 7 8 9 10 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 % 2,8-4.2% 2,7-5.3% 6,4-8,9% 0,3-0,5% 0,1% DỊCH TỄ HỌC 2
pmp: per million population Himmelfarb, J., Vanholder, R., Mehrotra, R. et al (2020), The current and future landscape of dialysis. Nat Rev Nephrol 16, 573–585 (2020) DỊCH TỄ HỌC 3
K/DOQI 11–12 g/dL CARI >11 g/dL CVD 12–14 g/dL no CVD UK RA >10 g/dL EBPG >11 g/dL (upper limit individualised) 2000 2001 2002 2003 2004 2005 2006 2007 K/DOQI ≥11 g/dL (caution >13 g/dL) K/DOQI 2007 update 11–12 g/dL (not intentionally >13 g/dL) UK NICE 10.5–12.5 g/dL 10–12 g/dL in children <2 yr 2008 2009 CARI 11–12 g/dL CVD 12–14 g/dL no CVD 2010 ERBP Position statement 11–12 g/dL (shoult not >13 g/dL) 2011 K/DOQI 2012 update Open (ND: not initiated ESA when Hb>10 g/dL; 5D: initiated ESA when Hb < 9 g/dL; No ESA if Hb >11.5 g/dL; not intentionally >13 g/dL) 2012 KDIGO 11.5 g/dL 4 MỤC TIÊU HEMOGLOBIN